Lung Cancer Annotated Bibliography
Student’s Name
Institutional Affiliation
Lung Cancer Annotated Bibliography
Detterbeck, F. C., Boffa, D. J., Kim, A. W., & Tanoue, L. T. (2017). The eighth edition lung cancer stage classification. Chest, 151(1), 193-203.
As of January 2017, a new global standard of cancer stage classification was launched. The cancer stage classification is done according to the anatomic extent that cancer has grown or spread in the patient’s body. Health professionals need to be aware of the classification stages of lung cancer when dealing with patients to ensure that any treatment or therapy offered is ineffective for that particular stage.
Kim, E. S. (2016). Chemotherapy resistance in lung cancer. In Lung Cancer and Personalized Medicine (pp. 189-209). Springer, Cham.
For a long time, chemotherapy has been a common type of treatment for both types of lung cancer. It has been discovered that with time a patient’s body might develop resistance to chemotherapy, which limits the ability to deal with cancer. Researchers need to come up with new treatment strategies that overcome the resistance of chemotherapy.
Herbst, R. S., Morgensztern, D., & Boshoff, C. (2018). The biology and management of non-small cell lung cancer. Nature, 553(7689), 446-454.
Over the years, significant advancements have taken place in the medical world, which has enabled the treatment of non-small cell lung cancer that has been achieved by having enough knowledge of the tumor’s biology. Immunotherapy and the small molecule tyrosine kinase inhibitors have increased the survival rates for some patients. More research and advancement in this condition will lead to new drugs and therapies that will help deal with NSCLC.
Hirsch, F. R., Scagliotti, G. V., Mulshine, J. L., Kwon, R., Curran Jr, W. J., Wu, Y. L., & Paz-Ares, L. (2017). Lung cancer: current therapies and new targeted treatments. The Lancet, 389(10066), 299-311.
In the quest to treat the top-ranked killer type of cancer, the elderly and those patients with poor performance status are considered as a special group that requires different treatment from the others. The treatment and therapies for lung cancer are only meant to maintain the effects of the condition but not to cure it. The best thing that an individual can do is to stop smoking to prevent one from contracting this killer disease.
Malhotra, J., Malvezzi, M., Negri, E., La Vecchia, C., & Boffetta, P. (2016). Risk factors for lung cancer worldwide. European Respiratory Journal, 48(3), 889-902.
In most cases of lung cancer, the primary cause has been smoking cigarettes, as elements are considered main Aetiological factors in lung carcinogenesis. It is also important to note that there are other factors such as air pollution, genetic susceptibility, occupational exposure, and poor diet can contribute to lung cancer, and people should be more careful to prevent it.
Torre, L. A., Siegel, R. L., & Jemal, A. (2016). Lung cancer statistics. In Lung cancer and personalized medicine (pp. 1-19). Springer, Cham.
Lung cancer is the leading cause of death in both men and women in the USA, while worldwide statistics cause death in men, and it is ranked second in causing cancer-related deaths in women. Statistically, lung cancer is prominent in the parts of the world where smoking is prevalent and among people of the lower socioeconomic status.